BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12805402)

  • 21. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity.
    Sarzani R; Strazzullo P; Salvi F; Iacone R; Pietrucci F; Siani A; Barba G; Gerardi MC; Dessì-Fulgheri P; Rappelli A
    Obes Res; 2004 Feb; 12(2):351-6. PubMed ID: 14981229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus.
    Roussel R; Reis AF; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):237-41. PubMed ID: 12864802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome.
    Sookoian SC; González C; Pirola CJ
    Obes Res; 2005 Dec; 13(12):2122-31. PubMed ID: 16421346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population.
    Romeo S; Sentinelli F; Cavallo MG; Leonetti F; Fallarino M; Mariotti S; Baroni MG
    Int J Obes (Lond); 2008 Mar; 32(3):413-20. PubMed ID: 17912268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population-based studies.
    van Dam RM; Hoebee B; Seidell JC; Schaap MM; Blaak EE; Feskens EJ
    Diabet Med; 2004 Jul; 21(7):752-8. PubMed ID: 15209769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity.
    Stefan N; Stumvoll M; Machicao F; Koch M; Häring HU; Fritsche A
    Obes Res; 2004 Apr; 12(4):679-83. PubMed ID: 15090636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity.
    Marti A; Ochoa MC; Sánchez-Villegas A; Martínez JA; Martínez-González MA; Hebebrand J; Hinney A; Vedder H
    BMC Med Genet; 2006 May; 7():50. PubMed ID: 16725041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 5-year follow-up study of 3 polymorphisms in the human glucocorticoid receptor gene in relation to obesity, hypertension, and diabetes.
    Rosmond R; Holm G
    J Cardiometab Syndr; 2008; 3(3):132-5. PubMed ID: 18983327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group.
    Flores-Martínez SE; Islas-Andrade S; Machorro-Lazo MV; Revilla MC; Juárez RE; Mújica-López KI; Morán-Moguel MC; López-Cardona MG; Sánchez-Corona J
    Ann Genet; 2004; 47(4):339-48. PubMed ID: 15581831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the FOXC2 -512C>T polymorphism in type 2 diabetes: possible association with the dysmetabolic syndrome.
    Carlsson E; Groop L; Ridderstråle M
    Int J Obes (Lond); 2005 Mar; 29(3):268-74. PubMed ID: 15597109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy.
    Szabó V; Borgulya G; Filkorn T; Majnik J; Bányász I; Nagy ZZ
    Mol Vis; 2007 Apr; 13():659-66. PubMed ID: 17563720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptide-Y Y1 receptor gene polymorphism: cross-sectional analyses in essential hypertension and obesity.
    Herzog H; Selbie LA; Zee RY; Morris BJ; Shine J
    Biochem Biophys Res Commun; 1993 Oct; 196(2):902-6. PubMed ID: 7902088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients.
    Di Blasio AM; van Rossum EF; Maestrini S; Berselli ME; Tagliaferri M; Podestà F; Koper JW; Liuzzi A; Lamberts SW
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):68-74. PubMed ID: 12807506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of coronary artery disease with glucocorticoid receptor N363S variant.
    Lin RC; Wang XL; Morris BJ
    Hypertension; 2003 Mar; 41(3):404-7. PubMed ID: 12623935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-protein beta3 subunit gene splice variant in obesity and overweight.
    Benjafield AV; Lin RC; Dalziel B; Gosby AK; Caterson ID; Morris BJ
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):777-80. PubMed ID: 11439289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overrepresentation of the N363S variant of the glucocorticoid receptor gene in patients with bilateral adrenal incidentalomas.
    Majnik J; Patocs A; Balogh K; Toth M; Gergics P; Szappanos A; Mondok A; Borgulya G; Panczel P; Prohaszka Z; Racz K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2796-9. PubMed ID: 16636127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease.
    Giordano R; Marzotti S; Berardelli R; Karamouzis I; Brozzetti A; D'Angelo V; Mengozzi G; Mandrile G; Giachino D; Migliaretti G; Bini V; Falorni A; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):863-70. PubMed ID: 22587831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.